Mercer Global Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
76,524
+42,063
+122% +$154K ﹤0.01% 2828
2026
Q1
$136K Buy
34,461
+13,675
+66% +$68.9K ﹤0.01% 2940
2025
Q4
$141K Buy
20,786
+5,236
+34% +$36.7K ﹤0.01% 2654
2025
Q3
$109K Buy
+15,550
New +$108K ﹤0.01% 2506
2022
Q2
Sell
-12,000
Closed -$57K 1882
2022
Q1
$57K Hold
12,000
﹤0.01% 1832
2021
Q4
$72K Sell
12,000
-42,200
-78% -$293K ﹤0.01% 1739
2021
Q3
$328K Hold
54,200
﹤0.01% 1385
2021
Q2
$678K Buy
+54,200
New +$587K 0.01% 1009

Other funds holding MDXG

Mercer Global Advisors's MDXG Position: Q2 2026 in Review

Mercer Global Advisors increased its MiMedx Group (MDXG) stake by 122% in Q2 2026, buying an estimated $154K and bringing the position to 76,524 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

Mercer Global Advisors first reported a position in MDXG in Q2 2021 and has held it in 8 quarters since. The position peaked at $678K in Q2 2021. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Mercer Global Advisors held 76,524 shares of MiMedx Group worth $295K as of Q2 2026.
  • Mercer Global Advisors bought 42,063 MiMedx Group shares in Q2 2026, an estimated $154K.
  • MiMedx Group made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2828 holding.
  • Mercer Global Advisors first reported a position in MiMedx Group in Q2 2021 and has held it in 8 quarters since.
  • Mercer Global Advisors's MiMedx Group position peaked at $678K in Q2 2021.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.